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Background
Radiation therapy along with surgery and chemotherapy are the major
therapeutic strategies for cancer treatment. It involves the delivery of
high intensity ionizing radiation with high accuracy to the tumor tissue
resulting in the death of tumor cells. Radiation sensitization is a
process of enhancing the susceptibility of tumor tissues to injury by
radiation exposure. Hence, radiosensitizers are therapeutic or otherwise
inert agents that enhance the effects of radiation therapy.1
Hyperthermia (also called thermal therapy or thermotherapy) is a type
of cancer treatment in which body tissue is exposed to high
temperatures (up to 45°C). Hyperthermia is almost always used with
other forms of cancer therapy, such as radiation therapy and
chemotherapy. Hyperthermia may make some cancer cells more
sensitive to radiation or harm other cancer cells that radiation cannot
damage. When hyperthermia and radiation therapy are combined, they
are often given within an hour of each other. Hyperthermia can also
enhance the effects of certain anticancer drugs. Magnetic nanoparticles
(MNP) can induce localized hyperthermia when exposed to an
alternating magnetic field (AMF).3,4
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Quantum dots as Radiosensitizers: The mechanism of action for these is based on the principle of generation of radicals upon absorption of 
visible light by the quantum dots. Since these light waves have much less toxicity as compared X-rays or gamma rays, the overall adverse 
effects of the therapy are greatly reduced. The major disadvantage of this approach is that light waves within the visible spectrum have very 
little penetration depth and hence the therapies designed utilizing these mechanisms will be suitable only for superficial cancers.1
Gold Nanoparticles: Gold is biocompatible and it enhances the effect of the radiation over a large area of tumor thus eliminating the need of 
the nanoparticles to be delivered to all the cells of the tumor tissue. It is much easier to perform overall and tissue specific pharmacokinetic 
studies with the gold nanoparticles as they are easy to image and quantify. Thus the dose levels can be optimized for best results.1
ZnFe2O4 Nanoparticle: Zinc-iron oxide particles have an effective atomic number higher than the effective atomic number of the body's 
tissues. When used as a radiosensitizer, these nanoparticles showed increase in absorbed dose and increase in radiation effect of the therapy.2
Fe3O4 Nanoparticles: Magnetic nanoparticles  are promising materials for hyperthermia treatment, as well as radiation sensitizing agents. 
Relative to other nanoparticles considered for radiation sensitization, they are highly biocompatible, and well suited for adjuvant hyperthermia 
applications.6
Figure 1: Summary of various 
approaches for enhancing the 
radiosensitization in cancer cells 
(top). Possible radiation 
interactions with high Z materials 
(bottom). 
.
Hypothesis: the addition of MNP to ionizing radiation increases the production of 
reactive oxygen species (ROS).
By increasing the DNA damage due to ROS, MNP have the potential to potentiate local 
radiation. Whether ROS production is increased by the presence of MNP will be examined 
through in vitro studies which utilize the Dichloro-dihydro-fluorescein diacetate (DCFH-
DA) assay to measure the changes in ROS due to the presence of MNP.7 Related to this 
concept, is the question whether intracellular vs. extracellular MNP are more effective at 
generating cytotoxicity. Significant efforts have been made to increase the intracellular 
nature of MNP as a means of inducing intracellular heating with AMF exposure. Whether 
there are significant benefits or differences resulting from intracellular heating remain 
unresolved in the field. Furthermore, the difference in cytotoxicity of intracellular vs. 
extracellular MNP combined with radiation is also not understood. Variables will include 
not only intracellular vs. extracellular MNP, but cell density (pelleted vs. isolated plated 
cells), and radiation type and energy. Finally, the addition of AMF induced heating will 
also be included to determine its effect on both the achieved cytotoxicity and ROS levels.5
(Kwatra 2013)
(Kwatra 2013)
Figure 2: Transmission electron microscopy image of 
MNP located within an MTGB mouse mammary 
adenocarcinoma cell, following intratumoral injection. 
The clustering and intracellular uptake near nucleus 
may enhance the cytotoxicity of radiation therapy.
